Hillig R C, Coulie P G, Stroobant V, Saenger W, Ziegler A, Hülsmeyer M
Institut für Immungenetik, Universitätsklinikum Charité, Humboldt-Universität zu Berlin, Germany.
J Mol Biol. 2001 Jul 27;310(5):1167-76. doi: 10.1006/jmbi.2001.4816.
The heterotrimeric complex of the human major histocompatibity complex (MHC) molecule HLA-A0201, beta2-microglobulin and the decameric peptide GVYDGREHTV derived from the melanoma antigen (MAGE-A4 protein has been determined by X-ray crystallography at 1.4 A resolution. MAGE-A4 belongs to a family of genes that are specifically expressed in a variety of tumours. MAGE-A4-derived peptides are presented by MHC molecules at the cell surface to cytotoxic T-lymphocytes. As the HLA-A0201:MAGE-A4 complex occurs only on tumour cells, it is considered to be an appropriate target for immunotherapy. The structure presented here reveals potential epitopes specific to the complex and indicates which peptide residues could be recognised by T-cell receptors. In addition, as the structure could be refined anisotropically, it was possible to describe the movements of the bound peptide in more detail.
人类主要组织相容性复合体(MHC)分子HLA - A0201、β2 - 微球蛋白与源自黑色素瘤抗原(MAGE - A4蛋白)的十聚体肽GVYDGREHTV的异源三聚体复合物已通过X射线晶体学在1.4埃分辨率下确定。MAGE - A4属于在多种肿瘤中特异性表达的基因家族。MAGE - A4衍生的肽由MHC分子呈递至细胞表面给细胞毒性T淋巴细胞。由于HLA - A0201:MAGE - A4复合物仅出现在肿瘤细胞上,它被认为是免疫治疗的合适靶点。此处呈现的结构揭示了该复合物特有的潜在表位,并指出了哪些肽残基可被T细胞受体识别。此外,由于该结构可以进行各向异性精修,因此有可能更详细地描述结合肽的运动。